Tithon Animal Sciences, Inc.
  • Welcome
  • About
    • Organisational Structure
    • Officers, Directors and Advisors
  • Science
  • Technology
  • Product and Services
  • News
  • Contact
Select Page

Dr. Mike Hutchinson accepts appointment as a member of Tithon’s Executive Board of Directors

by admin | Nov 16, 2017 | News | 0 comments

Tithon is pleased to announce appointment of Dr. Michael Hutchinson, D.V.M., as a member of Tithon’s Executive Board of Directors. Dr. Hutchinson is a leading practitioner in stem cell therapy and is a highly sought after speaker at national and international...

Tithon Animal Sciences, Inc. announces the introduction of its PRIMOSTEM CPS for use in addressing animal degenerative medical conditions

by admin | Nov 1, 2016 | News | 0 comments

Tithon Animal Sciences, Inc., a California corporation, announced the introduction of its PRIMOSTEM CPStm, a proprietary method and process for veterinarian physicians to obtain non-immunogenic parathyroid hormone receptor positive pluripotent stem cells from their...

Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study

by admin | Sep 29, 2015 | News | 0 comments

Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study

Recent Posts

  • Dr. Mike Hutchinson accepts appointment as a member of Tithon’s Executive Board of Directors
  • Tithon Animal Sciences, Inc. announces the introduction of its PRIMOSTEM CPS for use in addressing animal degenerative medical conditions
  • Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study

Contact Us

11440 West Bernardo Ct, Suite 300
San Diego, CA 92127
1 888 780-2639

Latest News

  • Dr. Mike Hutchinson accepts appointment as a member of Tithon’s Executive Board of Directors
  • Tithon Animal Sciences, Inc. announces the introduction of its PRIMOSTEM CPS for use in addressing animal degenerative medical conditions
  • Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study

Search

Admin

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Tithon Animal Sciences, Inc, a subsidiary of Tithon Biotech, Inc. © 2016 All Rights Reserved | Legal Terms | Web Development by Kosta Paspaliaris